The MarketWatch News Department was not involved in the creation of this content. -- Grünenthal acquires Valinor Pharma in an all-stock deal and becomes the owner of the global rights to Movantik(R) ...

Valinor Pharma said today it was purchased by German pharmaceutical company Grünenthal for about $250 million in upfront cash consideration. Chicago-based Valinor makes Movantik, a prescription ...

Reading J.R.R. Tolkien's The Lord of the Rings or watching Peter Jackson's The Hobbit and Lord of the Rings movies may create ...

Parker Bennett is a graduate of Emerson College with more than 3 years of writing experience. He's been a fan and scholar of Tolkien's extended works for nearly his whole life, and is excited to be ...

Círdan the Shipwright is a familiar figure to those invested in The Lord of the Rings lore and the world of J.R.R. Tolkien’s legendarium. But those who are more casually acquainted with the franchise ...

Valinor’s academic collaborations with the Montgomery and Theis Labs will establish industry-standard benchmarks for assessing the clinical translatability of perturbation prediction models Valinor ...

Grünenthal acquires Valinor Pharma in an all-stock deal and becomes the owner of the global rights to Movantik® (naloxegol) Valinor Pharma had owned Movantik since early 2023 and leveraged Apollo Care ...